Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

References

• McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and Treatment of Multiple Sclerosis: a Review. JAMA. 2021;325(8):765–779. doi:10.1001/jama.2020.26858
   PubMed Web of Science ®Google Scholar
• Maurino J, Martínez-Ginés ML, García-Domínguez JM, et al. Workplace difficulties, health-related quality of life, and perception of stigma from the perspective of patients with Multiple Sclerosis. Mult Scler Relat Disord. 2020;41:102046. doi:10.1016/j.msard.2020.102046
   PubMed Web of Science ®Google Scholar
• Sainz de la Maza S, Maurino J, Borges M, et al. Measuring productivity loss in early relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2022;58:103398. doi:10.1016/j.msard.2021.103398
   PubMed Web of Science ®Google Scholar
• Morgan A, Tallantyre E, Ontaneda D. The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis. Expert Rev Neurother. 2023;23(5):433–444.
   PubMed Web of Science ®Google Scholar
• Singer BA, Feng J, Chiong-Rivero H. Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption. J Neurol. 2024. doi:10.1007/s00415-024-12305-4
   PubMed Web of Science ®Google Scholar
• Schmidt S, Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple sclerosis: results of a cross-sectional study. Mult Scler Relat Disord. 2019;35:262–269. doi:10.1016/j.msard.2019.07.029
   PubMed Web of Science ®Google Scholar
• Chertcoff A, Schneider R, Azevedo CJ, et al. Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis. Neurol Clin. 2024;42(1):15–38. doi:10.1016/j.ncl.2023.06.008
   PubMed Web of Science ®Google Scholar
• Ubbink DT, Damman OC, de Jong BA. Shared decision-making in patients with multiple sclerosis. Front Neurol. 2022;13:1063904. doi:10.3389/fneur.2022.1063904
   PubMed Web of Science ®Google Scholar
• Webb EJD, Meads D, Eskyte I, et al. A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple Sclerosis. Patient. 2018;11(4):391–402. doi:10.1007/s40271-017-0296-y
   PubMedGoogle Scholar
• Eskyte I, Manzano A, Pepper G, et al. Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: a critical interpretive synthesis. Mult Scler Relat Disord. 2019;27:370–377. doi:10.1016/j.msard.2018.11.016
   PubMed Web of Science ®Google Scholar
• Różycka J. How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study. PLoS One. 2021;16(10):e0258740. doi:10.1371/journal.pone.0258740
   PubMed Web of Science ®Google Scholar
• LeBlanc A, Kenny DA, O’Connor AM, et al. Decisional conflict in patients and their physicians: a dyadic approach to shared decision making. Med Decis Making. 2009;29(1):61–68. doi:10.1177/0272989X08327067
   PubMed Web of Science ®Google Scholar
• Garvelink MM, Boland L, Klein K, et al. Decisional Conflict Scale Use over 20 Years: the Anniversary Review. Med Decis Making. 2019;39(4):301–314. doi:10.1177/0272989X19851345
   PubMed Web of Science ®Google Scholar
• Wilkie DD, Solari A, Nicholas R. Initiating disease-modifying treatments in multiple sclerosis: measuring the decision process using decisional conflict and decisional regret scales. Mult Scler J Exp Transl Clin. 2019;5(1):2055217319833006. doi:10.1177/2055217319833006
   Google Scholar
• Reen GK, Silber E, Langdon DW. Improving MS patients’ understanding of treatment risks and benefits in clinical consultations: a randomised crossover trial. Mult Scler Relat Disord. 2021;49:102737. doi:10.1016/j.msard.2021.102737
   PubMed Web of Science ®Google Scholar
• Cocco E, Caoci A, Lorefice L, et al. Perception of risk and shared decision making process in multiple sclerosis. Expert Rev Neurother. 2017;17(2):173–180. doi:10.1080/14737175.2016.1217155
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. doi:10.1016/S1474-4422(17)30470-2
   PubMed Web of Science ®Google Scholar
• Possa MF, Minacapelli E, Canale S, et al. The first year after diagnosis: psychological impact on people with multiple sclerosis. Psychol Health Med. 2017;22(9):1063–1071. doi:10.1080/13548506.2016.1274043
   PubMed Web of Science ®Google Scholar
• Janssens AC, de Boer JB, van Doorn PA, et al. Expectations of wheelchair-dependency in recently diagnosed patients with multiple sclerosis and their partners. Eur J Neurol. 2003;10(3):287–293. doi:10.1046/j.1468-1331.2003.00583.x
   PubMed Web of Science ®Google Scholar
• Hoffmann O, Paul F, Haase R, et al. Preferences, Adherence, and Satisfaction: three Years of Treatment Experiences of People with Multiple Sclerosis. Patient Prefer Adherence. 2024;18:455–466. doi:10.2147/PPA.S452849
   PubMed Web of Science ®Google Scholar
• Légaré F, Kearing S, Clay K, et al. Are you SURE?: assessing patient decisional conflict with a 4-item screening test. Can Fam Physician. 2010;56(8):e308–14.
   PubMed Web of Science ®Google Scholar
• Brodney S, Fj F Jr, Barry MJ, et al. Comparison of Three Measures of Shared Decision Making: SDM Process_4, CollaboRATE, and SURE Scales. Med Decis Making. 2019;39(6):673–680. doi:10.1177/0272989X19855951
   PubMed Web of Science ®Google Scholar
• Guerrero-Peral ÁL, Porta-Etessam J, Rodríguez-Vico J, et al. Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain. Patient Prefer Adherence. 2022;16:3291–3302. doi:10.2147/PPA.S384333
   PubMed Web of Science ®Google Scholar
• Wilski M, Brola W, Łuniewska M, et al. The perceived impact of multiple sclerosis and self-management: the mediating role of coping strategies. PLoS One. 2021;16(3):e0248135. doi:10.1371/journal.pone.0248135
   PubMed Web of Science ®Google Scholar
• Luca M, Eccles F, Perez Algorta G, et al. Illness perceptions and outcome in multiple sclerosis: a systematic review of the literature. Mult Scler Relat Disord. 2022;67:104180. doi:10.1016/j.msard.2022.104180
   PubMed Web of Science ®Google Scholar
• Maurino J, Sotoca J, Sempere ÁP, et al. High-Efficacy Disease-Modifying Therapies in People with Relapsing-Remitting Multiple Sclerosis: the Role of Risk Attitude in Treatment Decisions. Patient. 2021;14(2):241–248. doi:10.1007/s40271-020-00454-3
   PubMedGoogle Scholar
• Smith E, Langdon D. A systematic review to explore patients’ MS knowledge and MS risk knowledge. Neurol Sci. 2024. doi:10.1007/s10072-024-07541-5
   PubMed Web of Science ®Google Scholar
• Meca-Lallana J, Maurino J, Hernández-Pérez MÁ, et al. Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: quantifying the Patient’s Perspective. Neurol Ther. 2020;9(1):173–179. doi:10.1007/s40120-020-00176-6
   PubMed Web of Science ®Google Scholar
• Basu S, Poole J. The Brief Illness Perception Questionnaire. Occup Med (Lond). 2016;66(5):419–420. doi:10.1093/occmed/kqv203
   PubMed Web of Science ®Google Scholar
• Meca-Lallana V, Brañas-Pampillón M, Higueras Y, et al. Assessing fatigue in multiple sclerosis: psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5). Mult Scler J Exp Transl Clin. 2019;5(4):2055217319887987. doi:10.1177/2055217319887987
   Google Scholar
• Vickrey BG, Hays RD, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187–206. doi:10.1007/BF02260859
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar
• Giammanco MD, Polimeni G, Spadaro L, et al. An initial validation of the Italian Mishel Uncertainty Illness Scale (MUIS) for relapsing remitting multiple sclerosis patients. Neurol Sci. 2014;35(9):1447–1452. doi:10.1007/s10072-014-1781-x
   PubMed Web of Science ®Google Scholar
• Brehaut JC, O’Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281–292. doi:10.1177/0272989X03256005
   PubMed Web of Science ®Google Scholar
• Bishop M, Frain MP. The Multiple Sclerosis Self-Management Scale: revision and psychometric analysis. Rehabil Psychol. 2011;56(2):150–159. doi:10.1037/a0023679
   PubMed Web of Science ®Google Scholar
• Bessing B, Honan CA, van der Mei I, et al. Development and psychometric properties of the Multiple Sclerosis Knowledge Assessment Scale: rasch analysis of a novel tool for evaluating MS knowledge. Mult Scler. 2021;27(5):767–777. doi:10.1177/1352458520929626
   PubMed Web of Science ®Google Scholar
• Zhang DC, Highhouse S, Nye CD. Development and validation of the General Risk Propensity Scale (GRiPS). J Behav Dec Making. 2018;32(2):152–167.
   Web of Science ®Google Scholar
• Solari A, Giordano A, Kasper J, et al. Role Preferences of People with Multiple Sclerosis: image-Revised, Computerized Self-Administered Version of the Control Preference Scale. PLoS One. 2013;8(6):e66127. doi:10.1371/journal.pone.0066127
   PubMed Web of Science ®Google Scholar
• López-Góngora M, Querol L, Escartín A. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. BMC Neurol. 2015;15:40. doi:10.1186/s12883-015-0296-2
   PubMed Web of Science ®Google Scholar
• Boland L, Légaré F, McIsaac DI, et al. SURE Test Accuracy for Decisional Conflict Screening among Parents Making Decisions for Their Child. Med Decis Making. 2019;39(8):1010–1018. doi:10.1177/0272989X19884541
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim Y, Jeong K, et al. Logistic LASSO regression for the diagnosis of breast cancer using clinical demographic data and the BI-RADS lexicon for ultrasonography. Ultrasonography. 2018;37(1):36–42. doi:10.14366/usg
   PubMed Web of Science ®Google Scholar
• Han PKJ, Babrow A, Hillen MA, et al. Uncertainty in health care: towards a more systematic program of research. Patient Educ Couns. 2019;102(10):1756–1766. doi:10.1016/j.pec.2019.06.012
   PubMed Web of Science ®Google Scholar
• Bansback N, Chiu JA, Metcalfe R, et al. Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211029966. doi:10.1177/20552173211029966
   Google Scholar
• Köpke S, Solari A, Rahn A, et al. Information provision for people with multiple sclerosis. Cochrane Database Syst Rev. 2018;10(10):CD008757. doi:10.1002/14651858.CD008757.pub3
   PubMedGoogle Scholar
• Bradson ML, Strober LB. Coping and psychological well-being among persons with relapsing-remitting multiple sclerosis: the role of perceived self-efficacy. Mult Scler Relat Disord. 2024;84:105495. doi:10.1016/j.msard.2024.105495
   PubMed Web of Science ®Google Scholar
• Becerra Pérez MM, Menear M, Brehaut JC, et al. Extent and Predictors of Decision Regret about Health Care Decisions: a Systematic Review. Med Decis Making. 2016;36(6):777–790. doi:10.1177/0272989X16636113
   PubMed Web of Science ®Google Scholar
• Diotaiuti P, Valente G, Mancone S, et al. The use of the Decision Regret Scale in non-clinical contexts. Front Psychol. 2022;13:945669. doi:10.3389/fpsyg.2022.945669
   PubMed Web of Science ®Google Scholar
• Rahn AC, Solari A, Beckerman H, et al. “I Will Respect the Autonomy of My Patient”: a Scoping Review of Shared Decision Making in Multiple Sclerosis. Int J MS Care. 2020;22(6):285–293. doi:10.7224/1537-2073.2020-027
   PubMedGoogle Scholar
• Dreesens D, Stiggelbout A, Agoritsas T, et al. A conceptual framework for patient-directed knowledge tools to support patient-centred care: results from an evidence-informed consensus meeting. Patient Educ Couns. 2019;102(10):1898–1904. doi:10.1016/j.pec.2019.05.003
   PubMed Web of Science ®Google Scholar
• Robles-Sanchez MA, Moharra M, Bosch-Farré C, et al. Views of Multiple Sclerosis Patients About Key Elements for a Decision Aid: a Qualitative Study. J Neurosci Nurs. 2023;55(5):164–170. doi:10.1097/JNN.0000000000000721
   PubMed Web of Science ®Google Scholar